相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms of ligand specificity of the mineralocorticoid receptor
Peter J. Fuller et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
Peter Kolkhof et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
Hari K. Parthasarathy et al.
JOURNAL OF HYPERTENSION (2011)
Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists
Tomoaki Hasui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
Jean-Philippe Bertocchio et al.
KIDNEY INTERNATIONAL (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
Jerome Fagart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy
Marvin J. Meyers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of Novel Cyanodihydropyridines as Potent Mineralocorticoid Receptor Antagonists
Graciela B. Arhancet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Stereochemical Requirements for the Mineralocorticoid Receptor Antagonist Activity of Dihydropyridines
Graciela B. Arhancet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Photosensitized Oxidations of Substituted Pyrroles: Unanticipated Radical-Derived Oxygenated Products
Mariza N. Alberti et al.
JOURNAL OF ORGANIC CHEMISTRY (2009)
A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity
Jessica D. Dietz et al.
HYPERTENSION (2008)
Synthesis of 7-substituted-(2,3-dihydro-1,4-benzodioxin-5-yl)-piperazine
Fabio Rancati et al.
SYNTHETIC COMMUNICATIONS (2008)
Structural basis of spirolactone recognition by the mineralocorticoid receptor
Jessica Huyet et al.
MOLECULAR PHARMACOLOGY (2007)
Non-steroidal mineralocorticoid receptor antagonists
Marvin J. Meyers et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2007)
Spironolactone in type 2 diabetic nephropathy: effects on proteinuria, blood pressure and renal function
Anton H. van den Meiracker et al.
JOURNAL OF HYPERTENSION (2006)
Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget
ZM Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor
Y Li et al.
MOLECULAR CELL (2005)
Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone
X Hu et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms
ML Hultman et al.
MOLECULAR ENDOCRINOLOGY (2005)
The evolution of aldosterone antagonists
SM Garthwaite et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Potential therapeutic antioxidants that combine the radical scavenging ability of myricetin and the lipophilic chain of vitamin E to effectively inhibit microsomal lipid peroxidation
CJ Bennett et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Ruthenium porphyrin catalyzed intramolecular carbenoid C-H insertion. Stereloselective synthesis of cis-disubstituted oxygen and nitrogen heterocycles
WH Cheung et al.
ORGANIC LETTERS (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effectiveness of aldosterone blockade in patients with diabetic nephropathy
A Sato et al.
HYPERTENSION (2003)
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
MH Weinberger et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
分享论文
